Act Capital Management, LLC 13F holdings
Act Capital Management, LLC reported 62 positions with a total reported value of $153.1M as of 2026-06-30, in its 13F for Q2 2026, filed 2026-07-29. Top holdings by reported value: KRYS KRYSTAL BIOTECH INC (10.9%), TGTX TG THERAPEUTICS INC (9.0%), ABVX ABIVAX SA (8.4%), CVX CHEVRON CORP (8.1%), XOM EXXON MOBIL CORP (7.0%). Against 2026-03-31 it opened 20 new positions and exited 14. Next 13F due by 2026-11-14, the legal deadline 45 days after the quarter ending 2026-09-30.
Email me when Act Capital Management, LLC files its 13F
A free account follows up to 10 funds. New 13F filings arrive in your daily or weekly digest. No password and no card.
Top holdings
25 largest of 62 positions · reported value as of 2026-06-30
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| KRYS KRYSTAL BIOTECH INC | 45,000 | $16.7M | 10.9% |
| TGTX TG THERAPEUTICS INC | 251,025 | $13.8M | 9.0% |
| ABVX ABIVAX SA | 97,000 | $12.9M | 8.4% |
| CVX CHEVRON CORP | 75,000 | $12.4M | 8.1% |
| XOM EXXON MOBIL CORP | 78,500 | $10.7M | 7.0% |
| ARWR ARROWHEAD PHARMACEUTICALS INC | 110,100 | $9.0M | 5.9% |
| VKTX VIKING THERAPEUTICS INC | 209,300 | $8.2M | 5.3% |
| CELC CELCUITY INC | 62,150 | $6.5M | 4.2% |
| NKTR NEKTAR THERAPEUTICS | 89,300 | $6.2M | 4.1% |
| TSLA TESLA INC | 10,800 | $4.5M | 3.0% |
| CYTK CYTOKINETICS INC | 47,500 | $4.0M | 2.6% |
| ASTS AST SPACEMOBILE INC | 43,500 | $3.9M | 2.5% |
| PVLA PALVELLA THERAPEUTICS INC | 22,500 | $3.4M | 2.2% |
| AMZN AMAZON.COM INC | 12,900 | $3.1M | 2.0% |
| NUVB NUVATION BIO INC | 520,000 | $3.0M | 1.9% |
| XENE XENON PHARMACEUTICALS INC | 48,000 | $2.9M | 1.9% |
| ET ENERGY TRANSFER L P | 133,100 | $2.5M | 1.7% |
| BE BLOOM ENERGY CORP | 7,500 | $2.3M | 1.5% |
| FCX FREEPORT-MCMORAN INC | 32,500 | $2.0M | 1.3% |
| NBIS NEBIUS GROUP NV | 6,800 | $1.9M | 1.2% |
| ALMS ALUMIS INC | 51,600 | $1.5M | 0.9% |
| AMBA AMBARELLA INC | 16,000 | $1.4M | 0.9% |
| CBRS CEREBRAS SYSTEMS INC | 5,600 | $1.2M | 0.8% |
| DFTX DEFINIUM THERAPEUTICS INC | 25,000 | $1.2M | 0.8% |
| NOK NOKIA CORP | 82,000 | $1.1M | 0.7% |
SEC FORM 13F · Q2 2026 · VALUES AS REPORTED, NOT PRICES
New positions this quarter
Held at 2026-06-30, not at 2026-03-31 · 20 in all · reported value as of 2026-06-30
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| TSLA TESLA INC | 10,800 | $4.5M | 3.0% |
| ASTS AST SPACEMOBILE INC | 43,500 | $3.9M | 2.5% |
| PVLA PALVELLA THERAPEUTICS INC | 22,500 | $3.4M | 2.2% |
| NBIS NEBIUS GROUP NV | 6,800 | $1.9M | 1.2% |
| AMBA AMBARELLA INC | 16,000 | $1.4M | 0.9% |
| CBRS CEREBRAS SYSTEMS INC | 5,600 | $1.2M | 0.8% |
| DFTX DEFINIUM THERAPEUTICS INC | 25,000 | $1.2M | 0.8% |
| NOK NOKIA CORP | 82,000 | $1.1M | 0.7% |
| CCJ CAMECO CORP | 8,400 | $855.6K | 0.6% |
| MLYS MINERALYS THERAPEUTICS INC | 28,100 | $758.1K | 0.5% |
| PLTR PALANTIR TECHNOLOGIES INC | 5,500 | $641.7K | 0.4% |
| ON ON SEMICONDUCTOR CORP | 6,000 | $567.2K | 0.4% |
| KEEL KEEL INFRASTRUCTURE CORP | 74,500 | $427.6K | 0.3% |
| CRVS CORVUS PHARMACEUTICALS INC | 27,000 | $403.4K | 0.3% |
| AXTI AXT INC | 4,900 | $353.2K | 0.2% |
| INFQ INFLEQTION INC | 25,000 | $333.0K | 0.2% |
| ANL ADLAI NORTYE LTD | 27,000 | $310.5K | 0.2% |
| CEPL CAPSTONE ENERGY PLUS, INC. | 27,500 | $253.0K | 0.2% |
| VIVO VIVOPOWER PLC | 42,500 | $219.7K | 0.1% |
| SPCX SPACE EXPL TECHNOLOGIES CORP | 800 | $136.7K | <0.1% |
Sold out
Held at 2026-03-31, gone by 2026-06-30 · 14 in all · reported value as of 2026-03-31
| Holding | Shares 2026-03-31 | Reported value | % of portfolio then |
|---|---|---|---|
| STAA STAAR SURGICAL CO | 55,500 | $1.0M | 0.8% |
| S SENTINELONE INC | 54,300 | $699.4K | 0.5% |
| LITE LUMENTUM HLDGS INC | 900 | $632.5K | 0.5% |
| CRCL CIRCLE INTERNET GROUP INC | 6,000 | $572.5K | 0.4% |
| NVDA NVIDIA CORPORATION | 2,800 | $488.3K | 0.4% |
| REPL REPLIMUNE GROUP INC | 61,500 | $470.5K | 0.4% |
| OLMA OLEMA PHARMACEUTICALS INC | 25,000 | $372.8K | 0.3% |
| INCY INCYTE CORP | 2,000 | $188.2K | 0.1% |
| CAPR CAPRICOR THERAPEUTICS INC | 5,000 | $152.0K | 0.1% |
| VPG VISHAY PRECISION GROUP INC | 3,000 | $130.3K | 0.1% |
| ESPERION THERAPEUTICS INC | 47,500 | $130.2K | 0.1% |
| AMLX AMYLYX PHARMACEUTICALS INC | 9,000 | $125.1K | <0.1% |
| LTRX LANTRONIX INC | 15,000 | $78.6K | <0.1% |
| HIMS HIMS &HERS HEALTH INC | 2,500 | $51.9K | <0.1% |
Biggest increases and decreases
Positions held at both quarter ends, by change in shares · reported value as of 2026-06-30
Increases
| Holding | Shares 2026-03-31 | Shares 2026-06-30 | Change | Reported value |
|---|---|---|---|---|
| ABVX ABIVAX SA | 70,900 | 97,000 | +36.8% | $12.9M |
| ARWR ARROWHEAD PHARMACEUTICALS INC | 82,500 | 110,100 | +33.5% | $9.0M |
| NUVB NUVATION BIO INC | 290,000 | 520,000 | +79.3% | $3.0M |
| NKTR NEKTAR THERAPEUTICS | 70,900 | 89,300 | +26.0% | $6.2M |
| XOM EXXON MOBIL CORP | 70,000 | 78,500 | +12.1% | $10.7M |
| BE BLOOM ENERGY CORP | 4,500 | 7,500 | +66.7% | $2.3M |
| XENE XENON PHARMACEUTICALS INC | 33,500 | 48,000 | +43.3% | $2.9M |
| GLUE MONTE ROSA THERAPEUTICS INC | 22,500 | 35,000 | +55.6% | $847.0K |
| CMPS COMPASS PATHWAYS PLC | 15,500 | 30,000 | +93.5% | $424.5K |
| KURA KURA ONCOLOGY INC | 73,900 | 88,900 | +20.3% | $975.2K |
| RGNX REGENXBIO INC | 56,000 | 67,500 | +20.5% | $808.6K |
| TGTX TG THERAPEUTICS INC | 249,025 | 251,025 | +0.8% | $13.8M |
Decreases
| Holding | Shares 2026-03-31 | Shares 2026-06-30 | Change | Reported value |
|---|---|---|---|---|
| KRYS KRYSTAL BIOTECH INC | 60,477 | 45,000 | -25.6% | $16.7M |
| AMZN AMAZON.COM INC | 33,000 | 12,900 | -60.9% | $3.1M |
| ALMS ALUMIS INC | 174,250 | 51,600 | -70.4% | $1.5M |
| CELC CELCUITY INC | 91,675 | 62,150 | -32.2% | $6.5M |
| AAOI APPLIED OPTOELECTRONICS INC | 25,900 | 6,000 | -76.8% | $889.0K |
| MU MICRON TECHNOLOGY INC | 1,500 | 200 | -86.7% | $230.9K |
| CYTK CYTOKINETICS INC | 64,500 | 47,500 | -26.4% | $4.0M |
| FCX FREEPORT-MCMORAN INC | 38,500 | 32,500 | -15.6% | $2.0M |
| WGS GENEDX HOLDINGS CORP | 8,000 | 4,000 | -50.0% | $274.6K |
| SRRK SCHOLAR ROCK HLDG CORP | 10,800 | 6,000 | -44.4% | $330.0K |
| PATH UIPATH INC | 50,000 | 30,000 | -40.0% | $326.1K |
| MBX MBX BIOSCIENCES INC | 9,000 | 8,000 | -11.1% | $441.6K |
CIK 1442273 · 13F FILINGS ON EDGAR · INFORMATIONAL ONLY
